Reinwald, Jonathan R.
Sartorius, Alexander
Weber-Fahr, Wolfgang
Sack, Markus
Becker, Robert http://orcid.org/0000-0003-4080-4452
Didriksen, Michael
Stensbøl, Tine B.
Schwarz, Adam J.
Meyer-Lindenberg, Andreas
Gass, Natalia http://orcid.org/0000-0001-7654-0570
Funding for this research was provided by:
Innovative Medicines Initiative (115008)
Deutsche Forschungsgemeinschaft (SA 1869/15-1, GA 2109/2-1, SA 1869/11-2)
Article History
Received: 9 October 2019
Revised: 17 February 2020
Accepted: 27 February 2020
First Online: 13 March 2020
Conflict of interest
: The authors declare no conflict of interest. A.J.S. is an employee of Takeda. M.D. and T.B.S. are employees of Lundbeck. A.M.L. has received consultant fees from Blueprint Partnership, Boehringer Ingelheim, Daimler und Benz Stiftung, Elsevier, F. Hoffmann-La Roche, ICARE Schizophrenia, K.G. Jebsen Foundation, L.E.K. Consulting, Lundbeck International Foundation (LINF), R. Adamczak, Roche Pharma, Science Foundation, Synapsis Foundation–Alzheimer Research Switzerland, and System Analytics and has received lectures including travel fees from Boehringer Ingelheim, Fama Public Relations, Institut d’investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Janssen-Cilag, Klinikum Christophsbad, Göppingen, Lilly Deutschland, Luzerner Psychiatrie, LVR Klinikum Düsseldorf, LWL Psychiatrie Verbund Westfalen-Lippe, Otsuka Pharmaceuticals, Reunions i Ciencia S.L., Spanish Society of Psychiatry, Südwestrundfunk Fernsehen, Stern TV, and Vitos Klinikum Kurhessen.